Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation
Dima, Delia, Trifa, Adrian P., Paţiu, Mariana, Vesa, Cristian S., Frinc, Ioana C., Petrov, Ljubomir, Cucuianu, Andrei
Correlation of cytomorphology with flowcytometric immunophenotyping in acute myeloid leukemia
Selicean, Elena-Cristina, Patiu, Mariana, Cucuianu, Andrei, Dima, Delia, Dobreanu, Minodora